|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
CrossFire Beilstein, CrossFire Gmelin and the Patent Chemistry Database form the CrossFire Database Suite. The suite represents a unique, deeply indexed source of experimental data in organic, inorganic and organometallic chemistry. The suite contains:
CrossFire Beilstein covers core organic chemistry since 1771 and patent publications from 1869-1980. CrossFire Beilstein provides all the organic chemistry information that chemists need to identify synthetic routes. Discovery scientists find physical substance data and can explore the pharmacological, ecological and toxicological outcomes. Specific bioassay results, pharmacodynamic parameters, logPs, toxicity values and other important types of data are all directly accessible. CrossFire Gmelin’s deep indexing makes it the essential first step in materials science and catalysis research. It is the only comprehensive, electronically searchable source of reactions, structures, properties and citations from inorganic and organometallic chemistry journals, with sources going back to 1772. Find millions of substances for development of materials, such as phosphors, catalysts and polymers, as well as other substances used in electronics, magnetics, optics and nanoscience. It covers general inorganic compounds, including: nano materials, zeolites and laser materials, as well as coordination compounds, solid-state compounds, glasses and ceramic materials, alloys, doped materials, catalysts and minerals.
EMBASE.com is the premier biomedical and pharmacological bibliographic literature search platform that searches EMBASE and MEDLINE simultaneously. Updated daily, it contains over 18 million indexed bibliographic records with abstracts. The file covers more than 7,000 journal titles published in 70 countries (close to 2,000 more titles than EMBASE or MEDLINE alone), including non-English language articles, and features extensive linking to full text, gene and protein sequence databases and PubChem. EMTREE, the life science thesaurus with 54,300 drug and medical descriptors, is fully integrated with EMBASE.com's targeted search forms and it may also be searched from the EMTREE Tool tab in EMBASE.com. MeSH terms are mapped to EMTREE and therefore may be searched in EMBASE.com. Share searching tips, see what other EMBASE.com; users have to say and have your say in future developments by signing up for the EMBASE.com forum. Simply click here and register with a username and password to start interacting with other users and the EMBASE.com team. Search tips are posted here on a regular basis as well as feedback topics. Click here to register for a free corporate trial. Sign up to register for a free online class.
With EMBASE OnSite, you receive data feeds directly from Elsevier, enabling you to host the entire EMBASE database yourself. Our flexible data format and delivery options allow you to incorporate EMBASE into your proprietary platforms. Optional features include thesaurus support (EMTREE), and full-text linking through DOIs or link resolvers. Click here to request a free trial for your company.
Do you need to stay up-to-date with commercial drug development and licensing activities? Inteleos provides the latest pipeline and regulatory information, clinical trials and news. Updated daily, using only primary sources, Inteleos content is structured for maximum user-friendliness and indexed and searchable to meet today’s scientific challenges, including biologics and comprehensive coverage of FDA (and soon EMEA) regulatory filings. In a recent survey 88% of our customers stated that they would recommend Inteleos to colleagues and peers, acknowledging that Inteleos is the most intuitive, flexible tool for drug pipeline research, tracking and analysis. Click here to request a free trial.
PharmaPendium is a unique online resource that puts drug safety data of US- approved drugs at a researcher's fingertips. This information repository lets researchers understand the full scope of projected risks early in the drug development process.
PharmaPendium is essential for:
Click here to request a free trial for your company.
ScienceDirect contains over 25% of the world's science, technology and medicine full text. It’s a reliable, easy-to-use electronic platform containing more than 8.5 million full-text articles published by Elsevier in some of the most prestigious journal titles worldwide. It’s clear, easy to use and can be counted on to deliver content that your research staff needs - directly to their desktops. ScienceDirect also offers online access to thousands of books including reference works, handbooks and book series. This year 4,000 book titles will be added as part of the eBooks on ScienceDirect program. The journal Backfiles program offers the ability to search a historical archive of over 6.75 million articles directly from your desktop, back to Volume 1, Issue 1. The collections contain 4 million articles prior to 1995, and 2.75 million articles from after 1994. xPharm, a state of the art, online, comprehensive pharmacology reference work. xPharm is comprised of four searchable and highly interlinked databases covering molecular Targets, including receptors, enzymes, transporters and ion channels, chemical Agents, including both drugs and endogenous compounds, clinical Disorders, and basic pharmacological Principles. There is a range of attractive ScienceDirect licensing options designed to suit your company’s specific requirements -- from purchasing a bundle of articles to providing company-wide access to the entire collection. Click here for details. Click here to request a free trial.
If you want to:
…you should be using Scopus helps your company make the connections that drive discovery and innovation forward and support critical business decisions. It is the largest abstract and citation database of peer-reviewed scientific, technical and medical literature and quality web sources – with smart tools to track, analyze and visualize research. If you want to find the right people, track the key research and stay ahead of the competition, you should be using the leading information solution – Scopus. Current and comprehensive, Scopus delivers:
Click here to request a free trial.
|
|
|
|